Table 2.
Subject characteristics
| Normal (n = 8) | Steatosis (n = 13) | NASH (n = 10) | |
|---|---|---|---|
| Height, m | 1.61 ± 0.03 | 1.68 ± 0.02 | 1.67 ± 0.06 |
| Sex, M/F | 1/7 | 4/9 | 3/7 |
| Body weight, kg | 136.0 ± 10.5 | 148.0 ± 11.8 | 154.2 ± 13.6 |
| Age at surgery, yr | 16.4 ± 0.9 | 17.1 ± 0.6 | 17.2 ± 0.4 |
| BMI | 51.9 ± 2.9 | 51.8 ± 3.6 | 54.7 ± 3.4 |
| BMI z-score | 2.6 ± 0.1 | 2.7 ± 0.1 | 2.8 ± 0.1 |
| NAS | 0 ± 0.0a | 1.5 ± 0.2b | 4.7 ± 0.4c |
| Insulin, pg/ml | 164.2 ± 48.2 | 255.6 ± 42.0 | 566.9 ± 186.9 |
| Glucose, mg/dl | 78.9 ± 3.2 | 82.4 ± 2.6 | 95.4 ± 10.4 |
| HOMA-IR | 0.8 ± 0.3a | 1.3 ± 0.2a | 3.4 ± 1.0b |
| Total cholesterol, mg/dl | 121.3 ± 4.8 | 124.9 ± 3.5 | 126.7 ± 3.2 |
| NEFA, mmol/l | 0.36 ± 0.09 | 0.36 ± 0.06 | 0.44 ± 0.08 |
| Triglycerides, mg/dl | 57.3 ± 5.4a | 77.7 ± 8.7a,b | 109.7 ± 17.9b |
Values are means ± SE. Different letter superscripts are significantly different (P < 0.05).
BMI, body mass index; NAS, nonalcoholic fatty liver disease (NAFLD) activity score; HOMA-IR, homeostatic model assessment/insulin resistance; NEFA, nonesterified fatty acids.